Probiotix Health (AQSE:PBX) Cash, Cash Equivalents, Marketable Securities : £1.95 Mil (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Cash, Cash Equivalents, Marketable Securities?

Probiotix Health's quarterly cash, cash equivalents, marketable securities declined from Jun. 2022 (£2.04 Mil) to Dec. 2022 (£1.54 Mil) but then increased from Dec. 2022 (£1.54 Mil) to Jun. 2023 (£1.95 Mil).

Probiotix Health's annual cash, cash equivalents, marketable securities declined from Dec. 2019 (£0.15 Mil) to Dec. 2020 (£0.13 Mil) but then increased from Dec. 2020 (£0.13 Mil) to Dec. 2022 (£1.54 Mil).

Probiotix Health Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Probiotix Health's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Cash, Cash Equivalents, Marketable Securities Chart

Probiotix Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec22

Cash, Cash Equivalents, Marketable Securities

0.15

0.13

1.54

Probiotix Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial			0.13	-	2.04	1.54	1.95

Probiotix Health Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Probiotix Health (AQSE:PBX) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Probiotix Health Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Probiotix Health's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Probiotix Health (AQSE:PBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

X90:Germany

Address

Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB

Website

https://www.probiotixhealth-ir.com

Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines